Valuation Marker Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 20:00:00 13/03/2026 GMT			5-day change	1st Jan Change
1.330 ^USD	-1.48%		-3.62%	-10.74%

11-14	Marker Therapeutics Q3 net loss narrows to $2 mln	RE
11-13	Marker Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	69.64	78.94	22.71	48.89	33.3	22.18	22.18	-
Change	-	13.36%	-71.23%	115.29%	-31.89%	-33.41%	0%	-
Enterprise Value (EV)	69.64	78.94	22.71	48.89	33.3	22.18	22.18	22.18
Change	-	13.36%	-71.23%	115.29%	-31.89%	-33.41%	0%	0%
P/E ratio	-2.38x	-1.73x	-0.74x	-	-2.61x	-1.41x	-0.92x	-1.4x
PBR	-	-	-	-	-	-	-	-
PEG	-	0.18x	0x	-	-	0.1x	-0x	0x
Capitalization / Revenue	149x	63.6x	2.52x	-	5.05x	7.16x	8.23x	1.14x
EV / Revenue	0x	0x	0x	-	0x	7.16x	8.23x	1.14x
EV / EBITDA	-	-	-	-	-0x	-1.54x	-1.33x	-1.39x
EV / EBIT	-0x	-0x	-	-	-0x	-1.52x	-0.91x	-0.99x
EV / FCF	-	-0x	-	-	-	-2.11x	-1.71x	-1.19x
FCF Yield	-	-38.5%	-	-	-	-47.4%	-58.6%	-84.3%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-6.1	-5.5	-3.58	-	-1.19	-0.9433	-1.44	-0.9533
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	0.4668	1.242	9.014	-	6.591	3.097	2.695	19.49
EBITDA ¹	-	-	-	-	-11.12	-14.39	-16.66	-15.99
EBIT ¹	-28.89	-39.48	-	-	-11.12	-14.63	-24.27	-22.33
Net income ¹	-28.71	-41.88	-	-8.237	-10.73	-13.8	-24.04	-19.93
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	14.500	9.502	2.659	5.500	3.110	1.330	1.330	1.330
Nbr of stocks (in thousands)	4,803	8,308	8,540	8,889	10,707	16,673	16,673	-
Announcement Date	09/03/21	17/03/22	22/03/23	25/03/24	31/03/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MARKER THERAPEUTICS, INC.	-1.41x	-	-	-	22.18M
LONZA GROUP AG	33.07x	4.92x	16.5x	1.02%	42.78B
BEONE MEDICINES AG	51.27x	4.42x	29.75x	-.--%	31.5B
CELLTRION, INC.	54.26x	11.14x	30.96x	0.35%	29.99B
IQVIA HOLDINGS INC.	19.97x	2.36x	10.18x	-.--%	27.65B
REVOLUTION MEDICINES, INC.	-12.38x	320.84x	-10.44x	-.--%	18.8B
ASCENDIS PHARMA A/S	43.12x	8.22x	25.82x	-.--%	13.87B
MEDPACE HOLDINGS, INC.	26.34x	4.19x	19.06x	-.--%	12.78B
EUROFINS SCIENTIFIC SE	20.1x	1.87x	8.16x	1.23%	12.39B
IONIS PHARMACEUTICALS, INC.	-17.61x	13.71x	-19.11x	-.--%	11.76B
Average	21.67x	41.30x	12.32x	0.29%	20.15B
Weighted average by Cap.	29.54x	35.39x	15.55x	0.34%